Heart rhythm disturbances as manifestations of cardiotoxicity of chemotherapy in the treatment of an ovarian cancer patient

Authors: Polikutina О.M. 1, Evtushenko V.V. 1, Zobnina А.V. 1, Borzyanitsa S.М. 2, Slepynina Yu.S. 1, Barbarash О.L. 1

Company: 1 Scientific Institution Research Institute for Complex Issues of Cardiovascular Diseases, Sosnovyy bul’var, 6, Kemerovo, 650002, Russian Federation
2 Regional Clinical Oncology Dispensary, Volgogradskaya ulitsa, 35, Kemerovo, 650036, Russian Federation

For correspondence:  Sign in or register.

Type:  Case reports


DOI: https://doi.org/10.24022/1997-3187-2018-12-2-177-182

For citation: Polikutina O.M., Evtushenko V.V., Zobnina A.V., Borzyanitsa S.M., Slepynina Yu.S., Barbarash O.L. Heart rhythm disturbances as manifestations of cardiotoxicity of chemotherapy in the treatment of a patient with ovarian cancer. Creative Cardiology. 2018; 12 (2): 177–82 (in Russ.). DOI: 10.24022/1997-3187-2018-12-2-177-182

Received / Accepted:  May 07, 2018 / May 14, 2018

Keywords: chemotherapy-induced cardiotoxicity cardiooncology heart rhythm disturbance

Download
Full text:  

 

Abstract

A clinical case of cardiotoxicity of chemotherapy in the treatment of a patient with ovarian cancer is presented. Outpatient management problems are discussed, and differential diagnostics questions are considered.

Acknowledgements. The study had no sponsorship.
Conflict of interest. The authors declare no conflict of interest.

References

  1. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guide- lines. Russian Journal of Cardiology. 2017; 3: 105–39. DOI: 10.15829/1560-4071-2017-3-105-139 (in Russ.)

  2. Witteles R.M., Bosch X. Myocardial protection during cardiotoxic chemotherapy. Circulation. 2015; 132: 1835–45. DOI: 10.1161/CIRCULA-TIONAHA.114.010486

  3. Moslehi J., Lenihan D.J. Cardio-oncology: time to get more mechanistic. JACC: Basic to trans- lational science. 2017; 2 (1): 54–5. DOI: 10.1016/j.jacbts.2017.01.002

  4. Seliverstova D.V., Evsina O.V. Cardiotoxicity of chemotherapy. Russian Heart Journal. 2016; 15 (1): 50–7.DOI: 10.18087/rhj.2016.1.2115 (in Russ.)

  5. Feyskhanova L.I., Malov A.A., Kharisova E.Kh. Heart injury induced by chemotherapy in oncology diseases. Russian Heart Failure Journal. 2015; 16 (5): 296–302. DOI: 10.18087/rhfj.2015.5.2109 (in Russ.).

  6. Nikitovic D., Juranek I., Wilks M.F., Tzardi M., Tsatsakis A., Tzanakakis G.N. Anthracycline- dependent cardiotoxicity and extracellular matrix remodeling. Chest. 2014; 146 (4): 1123–30. DOI: 10.1378/chest.14-0460

  7. Stenina M.B., Gladkov O.A., Kopp M.V., Koroleva I.V., Malygin S.E., Portnoy C.M. et al. Practical recommendations for correction of cardiovascular toxicity induced by chemotherapy and targeted drugs. Moscow; 2014: 360–8 (in Russ.).

  8. Fradley M.G., Neilan T.G. Cardiovascular out- comes in anthracycline-related cardiomyopathy. JACC: Clinical Electrophysiology. 2017; 3 (2): 151–3. DOI: 10.1016/j.jacep.2016.10.004

About Authors

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery